title: [Secondary and tertiary prevention of urological tumors].
abstract: The amount and quality of available data on secondary and tertiary prevention of urological tumors are to a large extent unsatisfactory. In the areas of nutrition and supplementary diet the consumption of tomatoes and especially tomato products could have a beneficial effect on the course of the disease for patients with prostate cancer, whereas there is evidence that the consumption of foodstuffs containing calcium (milk and milk products) and linolenic acid as well as a fat-rich diet accelerate tumor progression. Despite as yet unsatisfactory data, men with urothelial tumors or prostate cancer should abstain from smoking and undertake sports activities. For medicinal measures the administration of 5-alpha-reductase inhibitors and bone-promoting substances for patients with prostate cancer are under discussion. The effectiveness of the substances zoledronate and denosumab has been demonstrated in prospective randomized studies. The authors recommend that the scientifically neglected field of tertiary prevention of urological tumors should in future be included as a core factor of scientific investigations.
authors.affiliation: Urologie, EuromedClinic, Europa-Allee 1, 90763, Fürth, Deutschland. bsd@euromed.de
authors.forename: B J
authors.initials: BJ
authors.lastname: Schmitz-Dräger
authors.forename: G
authors.initials: G
authors.lastname: Lümmen
authors.forename: E
authors.initials: E
authors.lastname: Bismarck
authors.forename: C
authors.initials: C
authors.lastname: Fischer
mesh_terms: D058891:5-alpha Reductase Inhibitors / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D002295:Carcinoma, Transitional Cell / Q000209:etiology / Q000517:prevention & control / Q000534:rehabilitation; D003131:Combined Modality Therapy; D018450:Disease Progression; D005247:Feeding Behavior; D006801:Humans; D018551:Solanum lycopersicum; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000209:etiology / Q000517:prevention & control* / Q000534:rehabilitation; D008517:Phytotherapy; D011446:Prospective Studies; D011471:Prostatic Neoplasms / Q000209:etiology / Q000517:prevention & control / Q000534:rehabilitation; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D055502:Secondary Prevention; D055512:Tertiary Prevention; D001749:Urinary Bladder Neoplasms / Q000209:etiology / Q000517:prevention & control / Q000534:rehabilitation; D014571:Urologic Neoplasms / Q000209:etiology / Q000517:prevention & control* / Q000534:rehabilitation
chemical_list: D058891:5-alpha Reductase Inhibitors; D018931:Antineoplastic Agents, Hormonal; D050071:Bone Density Conservation Agents